CapsoVision (CV) Cash & Current Investments (2024 - 2025)
CapsoVision (CV) reported Cash & Current Investments of $10.1 million for Q4 2025, up 8.51% on a YoY basis from $9.3 million in Q4 2024, and down 43.15% sequentially from $17.8 million in Q3 2025.
CapsoVision (CV) Cash & Current Investments (2024 - 2025) Analysis & Trends
CapsoVision (CV) has 2 years of Cash & Current Investments data on file, last reported at $10.1 million in Q4 2025.
- For the quarter ending Q4 2025, Cash & Current Investments rose 8.51% year-over-year to $10.1 million; the trailing twelve-month figure through Dec 2025 stood at $10.1 million (up 8.51% YoY), and the FY2025 full-year result was $10.1 million, up 8.51% from the prior year.
- Cash & Current Investments fell to $10.1 million in Q4 2025, from $17.8 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $17.8 million in Q3 2025 to a low of $1.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.47 Bn | 176.17 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 129.01 Bn | 126.14 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 108.97 Bn | 99.75 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 68.46 Bn | 67.01 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 48.40 Bn | 44.73 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Dexcom | 28.37 Bn | 27.25 Bn | 750.30 Mn | 1.12 Bn |
| 7 | GE HealthCare Technologies | 28.36 Bn | 26.07 Bn | 1.98 Bn | 2.29 Bn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | 577.00 Mn |
| 9 | Koninklijke Philips | 25.46 Bn | 22.33 Bn | 2.07 Bn | 3.12 Bn |
| 10 | CapsoVision | 161.57 Mn | 151.46 Mn | 1.95 Mn | 10.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.11 Mn |
| Sep 30, 2025 | 17.79 Mn |
| Jun 30, 2025 | 1.07 Mn |
| Dec 31, 2024 | 9.32 Mn |